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The protein phosphatase 1 
regulator NIPP1 is essential for 
mammalian spermatogenesis
Mónica Ferreira1,2, Shannah Boens1, Claudia Winkler1, Kathelijne Szekér1, Iris Verbinnen1, 
Aleyde Van Eynde1, Margarida Fardilha2 & Mathieu Bollen1
NIPP1 is one of the major nuclear interactors of protein phosphatase PP1. The deletion of NIPP1 in 
mice is early embryonic lethal, which has precluded functional studies in adult tissues. Hence, we have 
generated an inducible NIPP1 knockout model using a tamoxifen-inducible Cre recombinase transgene. 
The inactivation of the NIPP1 encoding alleles (Ppp1r8) in adult mice occurred very efficiently in testis 
and resulted in a gradual loss of germ cells, culminating in a Sertoli-cell only phenotype. Before the 
overt development of this phenotype Ppp1r8−/− testis showed a decreased proliferation and survival 
capacity of cells of the spermatogenic lineage. A reduced proliferation was also detected after the 
tamoxifen-induced removal of NIPP1 from cultured testis slices and isolated germ cells enriched for 
undifferentiated spermatogonia, hinting at a testis-intrinsic defect. Consistent with the observed 
phenotype, RNA sequencing identified changes in the transcript levels of cell-cycle and apoptosis 
regulating genes in NIPP1-depleted testis. We conclude that NIPP1 is essential for mammalian 
spermatogenesis because it is indispensable for the proliferation and survival of progenitor germ cells, 
including (un)differentiated spermatogonia.
Spermatogenesis is a highly dynamic process that requires the coordinated proliferation and differentiation of 
male germ cells1–4. Spermatogonial stem cells (SSCs) represent the most primordial germ cells in adult testis; they 
divide cyclically to generate more stem cells (self-renewal) or progeny committed to differentiate into primary 
spermatocytes. The latter cells undergo a first meiotic division to form secondary spermatocytes, which rapidly 
enter the second meiotic division to produce spermatids. Finally, spermatids develop into spermatozoa during a 
differentiation process that involves major morphological changes. Spermatogenesis takes place in seminiferous 
tubules, which are surrounded by interstitial cells, including the testosterone-producing Leydig cells. The seminif-
erous tubules contain the full complement of germ cells, which gradually move from the periphery to the central 
lumen during maturation. The total number of germ cells in the seminiferous tubules is strictly controlled and 
mainly determined by coordination of cell proliferation and apoptosis5,6. The seminiferous tubules also contain 
Sertoli cells, which provide structural and metabolic support to the germ cells7,8.
Germ-cell proliferation and differentiation is tightly regulated by reversible protein phosphorylation9. While 
the role of various protein kinases has already been firmly established very little is known about the counteract-
ing phosphatases. Protein phosphatase 1 (PP1) catalyzes a major fraction of phospho-serine/threonine dephos-
phorylation reactions and it does so in a highly specific manner because it forms stable complexes with a host 
of PP1-interacting proteins that determine the activity and selectivity of the phosphatase10. Nuclear Inhibitor 
of PP1 (NIPP1; 351 residues in mouse), encoded by Ppp1r8, is one of the major nuclear interactors of PP1 and 
is expressed in nearly all eukaryotic cells. The N-terminal third of NIPP1 largely consists of a well-structured 
ForkHead-Associated (FHA) domain, while the remainder of the protein is intrinsically disordered but becomes 
partially structured upon binding to PP111. The FHA domain of NIPP1 mediates the recruitment of a subset of 
phosphoproteins, including the pre-mRNA splicing factors SAP155 and CDC5L12,13, protein kinase MELK14 and 
the methyltransferase EZH215, for regulated dephosphorylation by associated PP1. Consistent with the diversity 
of its FHA ligands, NIPP1 has been implicated in both transcription16–18 and pre-mRNA splicing19, and has estab-
lished contributions to cell proliferation and differentiation15,20–23.
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The global deletion of NIPP1 in mice is early embryonic lethal23. NIPP1−/− embryos show a reduced cell pro-
liferation potential and die at the gastrulation stage. In contrast, the selective removal of NIPP1 from liver epithe-
lial cells is not lethal, but results in an increased proliferation of biliary epithelial cells in the adult liver, including 
progenitor cells22. To further explore the exact function of NIPP1 in adult tissues we have generated an inducible 
knockout model. Here, we describe the testicular phenotype of the tamoxifen-induced deletion of NIPP1 in adult 
mice. Strikingly, the postnatal deletion of NIPP1 from testis results in the progressive loss of germ cells, leading 
to testicular hypoplasia within a few months. This correlates with a reduced proliferation and survival capacity of 
germ cells, including (un)differentiated spermatogonia. Our results demonstrate that NIPP1 is essential for the 
maintenance of the male germline and sustained spermatogenesis.
Results
Generation of an inducible NIPP1-knockout model. To study the postnatal functions of NIPP1 we 
generated an in vivo model for the inducible inactivation of Ppp1r8. Mice with floxed Ppp1r8 alleles (Ppp1r8fl/fl) 
were crossed with transgenic mice expressing tamoxifen-activated CRE-ERT2 recombinase under control of the 
Ubiquitin C (UBC) promotor (Supplementary Fig. 1a–c)24. Offspring with the Ubc-Cre-ERT2+/−; Ppp1r8fl/+ gen-
otype was crossed with heterozygous mice (Ppp1r8+/−). The resulting Ubc-Cre-ERT2+/−; Ppp1r8fl/− mice were 
used as tamoxifen-inducible NIPP1 knockouts or iKOs (Fig. 1a, Supplementary Fig. 1a–c). Since the deletion of 
one Ppp1r8 allele does not affect the expression level of NIPP123, the heterozygous Ubc-Cre-ERT2+/−; Ppp1r8fl/+ 
mice were used as controls (CTRs). The adopted knockout strategy avoids phenotypic artefacts induced by CRE 
recombinase because one Ppp1r8 allele is inactivated by tamoxifen-induced recombination in both the CTRs and 
iKOs25.
Following 4 consecutive tamoxifen injections at the age of 4 weeks, the CTR and iKO mice were sacrificed 
2–16 weeks later (Fig. 1b). The iKO mice appeared healthy and did not display any overt phenotype, except for a 
slightly lower body weight at 12 weeks (Supplementary Fig. 1d). In fact, the only macroscopic phenotype after dis-
section was a gradually developing smaller testis size in the male iKOs (Fig. 1c and d). This correlated with a loss 
of NIPP1 from the testis, as shown by both immunohistochemistry (Fig. 1c) and immunoblotting (Fig. 1e and f). 
At the age of 6 weeks, the NIPP1 protein level in the iKO testis was already reduced to about 40% of that in 
CTR testis, and further decreased to about 20% at 9–12 weeks. The remaining NIPP1 in the iKOs was mainly 
expressed in interstitial cells (Fig. 1c). We confirmed that the expression level of NIPP1 in testis from wild-type 
and Ppp1r8+/− mice was the same (Supplementary Fig. 1e and f), justifying the use of heterozygotes as controls. 
Remarkably, in the accessory sex glands (seminal vesicles and agglutination glands) and epididymis, a depletion 
of NIPP1 was only detected in limited histological areas and this had no effect on the histological organization 
and size of these glands (Supplementary Fig. 2). This suggests that the tamoxifen-induced NIPP1 deletion is var-
iable between tissues and even within tissues, in accordance with previous findings26.
The postnatal deletion of NIPP1 leads to a loss of male germ cells. In adult mouse testis NIPP1 is 
expressed in both germ cells and somatic cells, including Sertoli cells (Supplementary Fig. 3). Immunostaining 
revealed NIPP1 expression in all types of germ cells, except in elongated terminally differentiated spermatids. At 
the age of 6 weeks, which is two weeks after the administration of tamoxifen, NIPP1 was largely removed from 
both germ cells and Sertoli cells (Fig. 1c and Supplementary 3c). This incited us to explore the fate of both cell types 
in the NIPP1 iKOs. H&E stainings revealed that the diameter of the seminiferous tubules gradually decreased due 
to a loss of germ cells (Fig. 2a and b). In testis of 9 weeks, i.e. 5 weeks after the administration of tamoxifen, the 
seminiferous tubules already showed a clear decrease in the number of germ cells (Fig. 2a). The most severely 
affected tubules showed gross vacuolization and only contained few germ cells. By the age of 12 weeks all seminif-
erous tubules were histologically agametic and only contained Sertoli cells. However, the number of Sertoli cells 
per seminiferous tubule (SOX9 staining) was not affected by the deletion of NIPP1 (Fig. 2a and Supplementary 
Fig. 3d). These data imply that the testis from tamoxifen-treated iKO mice at 9 and 12 weeks are relatively enriched 
for Sertoli cells, as independently confirmed by SOX9 immunoblotting (Fig. 2c and d). At 20 weeks the Sertoli-cell 
only phenotype was still maintained, indicating that no new cycles of spermatogenesis had been started after 
week 9–12 (not shown). Quantitative RT-PCR for the global germ-cell marker Vasa27,28 and stage-specific 
germ cell markers for spermatogonia (Tacstd1, Plzf, Stra8)29–33, spermatocytes (Sycp3, Stmn1)34,35 and sper-
matids (Prm1, Tpn1)36,37, confirmed the progressive loss of these types of germ cells in the iKOs (Fig. 2e–g). 
Hence, the postnatal deletion of NIPP1 from testis results in the gradual loss of germ cells and culminates within 
a few cycles of spermatogenesis in a Sertoli-cell only phenotype.
The postnatal deletion of NIPP1 reduces the proliferation and survival of germ cells. We sub-
sequently examined whether the testis phenotype in the iKOs can be explained by a reduced proliferation and/or 
an increased apoptosis of germ cells. For these experiments, we used tamoxifen-treated mice of 6 weeks, when a 
testis phenotype is not yet histologically apparent (Fig. 2). Both BrdU (5′-bromo-2′-deoxyuridine) incorporation 
assays (Fig. 3a and b) and PCNA (proliferating cell nuclear antigen) stainings (Fig. 3a and c) disclosed a twofold 
lower proliferation rate of spermatogonia and (pre)leptotene spermatocytes in the iKOs. These conclusions were 
validated by immunoblotting for PCNA (Fig. 3d and e) and immunostainings for cyclin D2 and histone H3 
phosphorylation at Ser10 (H3S10P), which are markers for G1 and mitotic cells, respectively (Supplementary 
Fig. 4a–c). Finally, we confirmed that no significant loss of germ cells was detected yet in the iKOs at 6 weeks, as 
demonstrated by qRT-PCR data (Fig. 2e) and immunostainings for the spermatogonia marker PLZF (promyelo-
cytic leukemia zinc finger)29,30 (Fig. 3f and g).
TUNEL assays revealed a 3-fold increased level of apoptosis in germ cells from 7 weeks-old iKO mice (Fig. 3f 
and h). Apoptosis was particularly increased in germ cells from the basal layers of the seminiferous epithelium, 
comprising spermatogonia and early meiotic spermatocytes. Stainings for the senescence marker p16INK4a 
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Figure 1. The postnatal inactivation of Ppp1r8 in adult mice causes a reduced testis size. (a) Ppp1r8 alleles in 
control (CTR) and inducible NIPP1 knockout (iKO) mice. The exon numbers are indicated. (b) CTR and iKO 
mice express CRE-ERT2 recombinase under control of the UBC promoter (Ubc-Cre-ERT2). Scheme of the 4 
consecutive (every 2 days starting at the age of 4 weeks) intraperitoneal tamoxifen (TM) injections at the age of 
4 weeks (W) and subsequent testes sampling. d, days. (c) Macroscopic view of tamoxifen-injected testes from 
CTR and iKO mice at the age of 6, 9, 12 and 20 weeks (upper panels). The lower panels show DAPI (red) and 
NIPP1 (green) stainings of testis sections from tamoxifen-treated CTRs and iKOs at the indicated ages. Scale 
bar, 50 μm. (d) Testes gonadosomatic index, as determined by the percentage of total testis weight (g) over 
the body weight (g), of 6, 9, 12 and 20 weeks-old adult tamoxifen-treated CTR and iKO mice. (e,f) The level of 
NIPP1 in total testis extracts from tamoxifen-injected CTR and iKO mice was visualized by immunoblotting 
(e) and quantified (f). GAPDH was used as a loading control. Data are represented as means ± SEM (n = 4). 
**p < 0.01; ***p < 0.001. Uncropped blots are presented in Supplementary Fig. 8.
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(Supplementary Fig. 4a and d) and for fibrosis (Supplementary Fig. 4e) did not disclose differences between the 
CTRs and iKOs. Also, both groups contained similar proportions of tubules at different stages of development 
(Supplementary Fig. 4f). Collectively, our data indicate that the gradual loss of male germ cells after the deletion 
of NIPP1 is explained by their reduced proliferation and increased apoptosis rather than by the induction of 
Figure 2. The postnatal deletion of NIPP1 in adult mice leads to a loss of germ cells. (a) Testis sections 
of tamoxifen-injected CTR and iKO mice at the indicated ages were Hematoxylin-Eosin (H&E) stained 
or immunostained for the Sertoli-cell marker SOX9 (chromogenic DAB detection), with a Hematoxylin 
counterstain for the visualization of nuclei. Scale bar, 50 μm. (b) Quantification of cross-sectional diameter of 
the seminiferous tubules. (c,d) The level of SOX9 in total testis extracts from tamoxifen-injected CTR and iKO 
mice at the age of 6, 9 and 12 weeks was visualized by immunoblotting (c) and quantified (d). GAPDH was used 
as a loading control. (e–g) qRT- PCR analysis of the indicated genes, including markers for the different types of 
germ cells, at the indicated ages. Hprt was used as housekeeping gene for normalization. Spg. A, spermatogonia 
A; Spg. B, spermatogonia B; Spc., spermatocytes; Spt., spermatids. Data are represented as means ± SEM (n ≥ 3). 
*p < 0.05; **p < 0.01; ***p < 0.001.
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senescence or fibrosis. We also examined whether the loss of germ cells in the iKOs was associated with a desta-
bilization of NIPP1 ligands. However, immunoblotting of testicular lysates of mice of 6 weeks did not disclose a 
change in the level of three major protein interactors of NIPP1 in the iKOs, i.e. protein phosphatase PP1 or the 
splicing factors CDC5L and SAP155 (Supplementary Fig. 5).
Germ-cell proliferation is also reduced after the deletion of NIPP1 in cultured testis slices. To 
further explore the origin of the loss of germ cells in the iKOs, we have subsequently investigated whether this 
could be an indirect effect caused by the deletion of NIPP1 from peripheral tissues. For example, it could be 
Figure 3. Ppp1r8−/− testes show a reduced proliferation and survival of germ cells. (a) Testis sections of 
tamoxifen-treated mice of 6 weeks were immunostained for incorporated BrdU and the proliferation marker 
PCNA. Nuclei were visualized with propidium iodide (PI) or DAPI, as indicated. Scale bar, 50 μm. (b–c) 
Quantifications of the stainings as shown in panel (a) and performed as described in Materials and Methods. 
(d–e) The level of PCNA in total testis extracts from tamoxifen-injected CTR and iKO mice at the age of 6 weeks 
was visualized by immunoblotting (d) and quantified (e). TBP was used as a loading control. (f) Testis sections 
of tamoxifen-treated mice of 6 weeks were immunostained for the spermatogonial marker PLZF, and stained 
by a fluorochrome-based TUNEL assay to visualize apoptosis. Nuclei were visualized by DAPI. Scale bar, 50 
μm. (g,h) Quantifications of the stainings as shown in panel (f) and performed as described in Materials and 
Methods. All bar data are means ± SEM (n = 4). *p < 0.05; **p < 0.01; ***p < 0.001.
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argued that the deletion of NIPP1 from the brain interferes with the level of circulating testosterone, which is 
required for germ-cell survival38. However, the expression of NIPP1 in the iKOs was only marginally affected in 
the brain cortex and hypothalamus, and only reduced in a scattered fashion in the cerebellum (Supplementary 
Fig. 6a-d). Also, the levels of circulating testosterone at 9 weeks were similar in the CTRs and iKOs and there was 
no correlation between testosterone levels and testis weight (Supplementary Fig. 6e and f). To further differentiate 
between intrinsic and extrinsic defects, we aimed to generate a testis-specific NIPP1 mouse KO model by recom-
bination with Cre recombinase under control of the gonocyte-specific Vasa promotor (Supplementary Fig. 6g 
and h). However, the CRE-recombinase was expressed precociously, resulting in the global deletion of NIPP1, as 
has been reported for other Cre strains39. As an alternative approach to determine whether the testis phenotype 
was mediated by the loss of NIPP1 from peripheral tissues, we performed organ cultures using testis that were 
isolated from tamoxifen-treated mice of 6 weeks (Fig. 4a), or testis isolated at the age of 4 weeks and treated in 
vitro with hydroxytamoxifen (Fig. 4d). Under in vitro outgrowing conditions, BrdU incorporation (Fig. 4a–c) and 
the level of PCNA (Fig. 4d–f) were severely decreased in the iKOs, demonstrating that the observed phenotype 
is a testis-intrinsic defect.
NIPP1-depleted spermatogonia have a reduced proliferation capacity. Since our data suggested 
that the observed testis phenotype in the iKOs represents an intrinsic defect, we proceeded to examine the func-
tionality of Sertoli cells, as they are required for the maintenance of spermatogenesis40. qRT-PCR revealed that the 
Figure 4. The deletion of NIPP1 leads to a reduced proliferation of germ cells in cultured testis slices. (a) 
Testis from tamoxifen-treated CTR and iKO mice were isolated at 5 weeks and 3 days, and cultured for 4 days. 
After incubation for 6 h with BrdU, testis sections were H&E stained and immunostained for NIPP1 and 
incorporated BrdU. Nuclei were visualized with propidium iodide (PI) or DAPI as indicated. Scale bar, 50 µm. 
(b,c) Quantification of stainings for NIPP1 (b) and incorporated BrdU (c) as shown in panel (a). (d) Organ 
culture of testis slices that were isolated from non-treated CTRs and iKOs of 4 weeks. (Z)-4-Hydroxytamoxifen 
(4-OHT) was added to the slices for 96 hours to delete the floxed Ppp1r8 allele. Subsequently, testis sections were 
H&E stained, and immunostained for NIPP1 and PCNA. Nuclei were visualized by DAPI. Scale bar, 50 μm. (e,f) 
Quantification of stainings as shown in panel (d). All data in this figure are represented as means ± SEM (n = 4). 
*p < 0.05; **p < 0.01; ***p < 0.001.
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expression of factors secreted by Sertoli cells, including inhibins (Inhba and Inha) and the paracrine factor Gdnf 
that promotes spermatogonial stem cell self-renewal (Fig. 5a), were the same in the CTRs and iKOs. Only a minor 
decrease (~10%) of Gdnf was detected at 12 weeks, when all germ cells were already lost in the iKOs. As a com-
plementary approach, we performed RNA sequencing on whole testis isolated from tamoxifen-treated mice of 
6 weeks. Data analysis (FDR, <0.05; cut-off, 1.5 fold change) identified 122 upregulated and 152 downregulated 
genes in the iKOs, but did not disclose changed transcript levels of factors secreted by the Sertoli cells (Fig. 5b, 
Supplementary Table 1). An Ingenuity Pathway Analysis (IPA) (FDR, < 0.01; no cut-off) revealed that differen-
tially altered genes in the iKOs were mostly enriched for ‘Cell cycle’ in the IPA category ‘Molecular and Cellular 
functions’ (Fig. 5c). Among the cell-cycle classified genes ~75% were downregulated, including Kntc1, AurkA, 
Cenpt, Ccnb2, Nusap1 and Fancd2. In the IPA category ‘Physiological System Development and Function‘, most of 
the deregulated genes were assigned to ‘Reproductive system development and function’, including Tnk1, Nanos1, 
Pou3f3 and Lhx9. Finally, we also identified pro-apoptotic genes (Parp8, Bbc3, Ccnb3) that were upregulated in 
the iKOs. In general, these altered expression profiles are consistent with the observed decreased proliferation and 
survival potential of testicular cells in the iKOs. Key RNA sequencing data were largely confirmed by qRT-PCR 
(Fig. 5d). Taken together, these data suggested that the proliferation and survival of testicular cells is decreased in 
the iKOs, but this is not the consequence of an altered Sertoli-cell secretome.
Given the loss of the male germline in Ppp1r8−/− testis, we hypothesized that the progenitor germ cells, com-
prising (un)differentiated spermatogonia, have a reduced proliferation capacity after the deletion of NIPP1. Testis 
from 12 days old mice do not yet contain the full complement of germ cells that are present in adult testis but have 
a higher proportion of spermatogonia, including SSCs. First, we isolated testicular cells from non-treated mice 
Figure 5. The loss of NIPP1 is associated with the deregulation of cell-cycle and survival-related genes. (a) 
qRT-PCR analysis of genes encoding factors secreted by Sertoli cells, at the indicated ages. Sox9 was used for 
normalization. (b) Comparative RNA-sequencing profiling in testis of tamoxifen-treated mice of 6 weeks 
(n = 4). The figure shows the heat map of the significantly up- and downregulated genes. (c) Table showing the 
results of an IPA analysis of the genes that were significantly (FDR p < 0.01) affected by the deletion of NIPP1 
in testis of mice of 6 weeks. (d) qRT-PCR analysis showing differences at the level of the indicated transcripts 
between testis of CTRs and iKOs of 6 weeks. The depicted genes encode proteins with the same name except for 
Bbc3 and Cdkn2a, which encode PUMA and p16/INK4a, respectively. Data are represented as means ± SEM 
(n = 4). *p < 0.05; **p < 0.01; ***p < 0.001.
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of 12 days old and enriched these cells for undifferentiated spermatogonia by laminin selection41, as validated 
by qRT-PCR expression analysis (Fig. 6a). Indeed, the relative expression of the undifferentiated spermatogo-
nial markers Itga641–43, Itgb141–43 and Gfra144–47 was about 3-fold increased after laminin selection, while other 
stage-specific germ cell markers (Plzf and Stra8) and a Sertoli marker (Sox9) were decreased. Also, ~70% of 
laminin-selected cells were GFRA1 positive (Fig. 6b). When the isolated cells were cultured in vitro using SSC 
medium that contains GDFN to permit SSC proliferation independent of Sertoli cells, this resulted in the for-
mation of colonies as described41 (Fig. 6c). Subsequently, GFRA1-enriched testicular cells from both CTRs and 
iKOs were cultured and treated with hydroxytamoxifen for 72 h to delete NIPP1 in iKO cells. Immunostaining 
for NIPP1 and GFRA1 confirmed the efficient removal of NIPP1 in GFRA+ cells (Fig. 6d). The 4-OHT-induced 
deletion of NIPP1 in GFRA1-enriched cell cultures reduced their proliferation by some 40%, as demonstrated 
by BrdU incorporation assays (Fig. 6e and g), and increased the number of apoptopic cells, as shown by TUNEL 
assays (Fig. 6f and h). Consistent with these data, stainings for GFRA1 revealed that the number of GFRA1 
cells was reduced by ≈50% and ≈90% in tamoxifen-treated iKOs of 9 and 12 weeks, respectively (Fig. 6i and j). 
qRT-PCR analysis confirmed the gradual loss of GFRA1+ cells in tamoxifen-treated iKO (Fig. 6 l).
Finally, we also investigated the testis of tamoxifen-treated neonates of 7 days. At this age, the seminiferous 
tubules only contain a heterogeneous pool of gonocyte-derived (un)differentiated spermatogonia and Sertoli-cells 
(Supplementary Fig. 7a). In the neonatal iKOs NIPP1 was successfully deleted while the number of Sertoli cells 
(SOX9) was not significantly affected (Supplementary Fig. 7a–d). In contrast, the number of GFRA1+ cells was 
decreased by about 80%, showing that undifferentiated GFRA1+ spermatogonia are also depleted during the first 
wave of spermatogenesis when NIPP1 is absent (Supplementary Fig. 7a and b).
Discussion
The inactivation of both Ppp1r8 alleles in mice is early embryonic lethal23. This prompted us to develop an induc-
ible knockout model to study postnatal functions of NIPP1. The only macroscopic consequence of the deletion 
of NIPP1 in adult mice was a reduced testis size (Fig. 1). However, this does not preclude key functions for 
NIPP1 elsewhere as inactivation of the floxed Ppp1r8 allele by Ubc-Cre-ERT2 recombination was incomplete 
or patchy in all other examined tissues. Tamoxifen-induced Ubc-Cre-ERT2 recombination is indeed known 
to be tissue-dependent25,48. This has been explained by the unequal tissue distribution of injected tamoxifen, 
distinct chromatin compaction states of the targeted gene which determine its accessibility for Cre-mediated 
recombination and/or divergent Cre-ERT2 expression levels26,49. Nonetheless, Ubc-Cre-ERT2 recombination was 
very efficient in testis and the postnatal deletion of NIPP1 led to a gradual loss of sperm cells, culminating in a 
Sertoli-only phenotype (Fig. 2).
We have explored the events leading up to the testis phenotype in the iKOs. For this purpose, we mainly 
analyzed testes of mice of 6 weeks, i.e. two weeks after the administration of tamoxifen, when the seminifer-
ous tubules still appeared normal and the number of germ cells had not yet significantly decreased. Strikingly, 
at this age we already observed in the tamoxifen-treated iKOs a reduced proliferation and increased apoptosis 
of spermatogonia and early meiotic spermatocytes (Fig. 3). The reduced proliferation of germ cells was clearly 
a testis-intrinsic defect because this phenotype was also provoked by the hydroxytamoxifen-induced deletion 
of NIPP1 in cultured testis slices (Fig. 4). We speculate that the hypoproliferation defect is germ-cell autono-
mous because GFRA1-enriched cells showed in vitro a reduced proliferation after the deletion of NIPP1 (Fig. 6). 
Consistent with a germ-cell intrinsic defect, the secretome of the germ-cell supporting Sertoli cells (Fig. 5) and 
the release of testosterone by the Leydig cells (Supplementary Fig. 6) were not affected in the iKOs. It should be 
noted that the proposed contribution of NIPP1 to germ-cell proliferation and survival does not exclude addi-
tional functions for NIPP1 in testis, for example in meiotic germ cells.
The GFRA1-enriched cell population that we isolated comprises various subpopulations of spermatogonia, 
including spermatogonial stem cells (SCCs). Since GFRA1-enriched cells showed a reduced proliferation after 
the deletion of NIPP1 (Fig. 6), this suggests that NIPP1 may be required for the proliferation/selfrenewal of SSCs. 
This hypothesis can be further explored using SSC transplantation assays50,51. Intriguingly, while the loss of NIPP1 
in both testis (this work) and early embryo’s23 is associated with impaired cell proliferation, the selective depletion 
of NIPP1 in liver epithelial cells results in the hyperproliferation of biliary epithelial cells (BECs), including liver 
progenitor cells. Thus, NIPP1 emerges as a key regulator of cell proliferation, but its exact role is clearly tissue and 
context dependent.
Since NIPP1 controls the dephosphorylation of FHA ligands by associated PP1 (see Introduction), we hypoth-
esize that the proliferation defect in NIPP1-depleted testis stems from an altered phosphorylation status of FHA 
ligands. Among the established NIPP1 FHA ligands, the histone methyltransferase EZH1/2 and the splicing fac-
tor SAP155 are good candidates to mediate the testicular phenotype in the iKOs because these proteins have 
established functions in spermatogenesis52–54. However, we cannot exclude that other, hitherto unknown FHA 
ligands, contribute to the testicular phenotype. At first glance, the notion that the phenotype of Ppp1r8−/− testis is 
due to misregulated dephosphorylation of a subset of PP1 substrates seems at variance with observations that the 
genetic deletion of PP1α has no overt phenotype55. Likewise, the deletion of PP1γ causes male infertility56,57, but 
not a global loss of germ cells as seen after the deletion of NIPP1 (this work). These discrepancies can be explained 
by functional redundancy between the four PP1 isoforms (PP1α,PP1β, PP1γ1, PP1γ2) and the ability of NIPP1 to 
form complexes with all PP1 isoforms58. This implies that the loss of one PP1 isoform does not preclude the for-
mation of the PP1-NIPP1 holoenzyme and, therefore, does not cause a similarly strong phenotype as the deletion 
of NIPP1. The male infertility associated with the deletion of PP1γ is not necessarily due to a deficient function 
of PP1-NIPP1 but is probably caused by the loss of unique holoenzyme complexes between the splice variant 
PP1γ2 and PP1γ2-specific regulatory proteins in late-meiotic (pachytene spermatocytes) and post-meiotic germ 
cells55–57.
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Figure 6. NIPP1 depletion results in the hypoproliferation and progressive loss of (un)differentiated 
spermatogonia. (a) Testicular cells were isolated from 12 days old (P12) non-treated testis and enriched for 
undifferentiated spermatogonia using the laminin selection method. The graph shows qRT-PCR analysis of the 
indicated stage-specific markers for undifferentiated spermatogonia (Gfra1, Itgb1 and Itga6), spermatogonia 
(Plzf and Stra8) and Sertoli cells (Sox9), before and after laminin selection. The germ-cell specific marker 
Vasa was used for normalization. BLS, before laminin selection; ALS, after laminin selection. (b) Cells 
obtained by laminin selection were stained for DNA (DAPI) and GFRA1 (red). Arrows indicate GFRA1+ cells. 
Representative images are shown. (c) Cells that were acquired after the laminin selection as described in panel 
(a) were cultured for 72 h. Representative images generated by differential interference contrast (DIC) of paired 
cells (left), aligned cells (middle) or colony-forming cells (right) (d) Colonies from the CTR and iKO cells were 
treated for 72 h with 1 µM of 4-OHT and subsequently stained for DNA (DAPI), NIPP1 (green) and GFRA1 
(red). Arrows indicate GFRA1+ colonies formed after 96 h. *Mouse embryonic fibroblast (MEF) nucleus. 
Scale bar, 10 μm. (e–h) Hydroxytamoxifen-treated GFRA1-enriched cell cultures of CTR and iKO cells, as 
described in panel (d), were stained for DNA (DAPI), incorporated BrdU (e) and apoptosis by TUNEL assay 
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In conclusion, we have shown here that the postnatal deletion of NIPP1 in testis reduces the proliferation and 
survival potential of spermatogonia and culminates within a few months in the loss of all germ cells. Our data 
identify NIPP1 as an essential regulator of mammalian spermatogenesis.
Materials and Methods
Handling of mice. Mice were housed in a specific-pathogen free facility under standard 12 h light/dark 
cycles with water and food ad libitum. All experiments were approved by the KU Leuven Ethical Committee 
(P036/2013) and executed according to their guide of care of experimental animals. Ubc-Cre-ERT2/Ppp1r8fl/+ 
(CTR) and Ubc-Cre-ERT2/Ppp1r8fl/− (iKO) mice were generated using the breeding scheme shown in 
Supplementary Fig. 1a, involving previously described Ppp1r8+/− 23, Ppp1r8fl/fl22 and Ubc-Cre-ERT2 mice24 (a 
kind gift from Dr. M. Baes, KU Leuven, Belgium). A germ cell-specific NIPP1 mouse KO model was generated 
as detailed in Supplementary Fig. 5g, using transgenic Vasa-Cre mouse59 (a kind gift from Dr. D.H. Castrillon, 
University of Texas Southwestern Medical Center, USA). For genotyping, tail-clip or ear-clip DNA was amplified 
by PCR, using the primer sets described in Supplementary Table 2. The PCR conditions are available on request.
Tamoxifen (Sigma-Aldrich) was dissolved in 10% (v/v) ethanol in oil at a concentration of 20 mg/ml. Deletion 
of the floxed Ppp1r8 allele in adult males was induced by 4 consecutive intraperitoneal injections (every 2 days 
starting at the age of 4 weeks) of 0.2 mg tamoxifen/g body weight (Fig. 1b). Deletion of the floxed Ppp1r8 allele in 
neonates was induced by 3 daily subcutaneous injections, of 0.2 mg tamoxifen/g body weight, starting from 1 day 
post-partum (dpp), (Supplementary Fig. 7a). BrdU (Sigma) was dissolved in phosphate-buffered saline (PBS) 
and injected intraperitoneally at 100 mg per kg mouse body weight. Testes were harvested 2 h following BrdU 
injections. The testes from anaesthetized animals were either directly frozen in liquid nitrogen, fixed in Bouin’s 
(Sigma-Aldrich) or 4% Paraformaldehyde (PFA) solutions.
Organ and cell culture. Testis organ culture was performed as described60,61. Briefly, testis from adult male 
mice were decapsulated by removal of the tunica albuginea and subsequently divided with forceps into 4 pieces 
of approximately 2 mm diameter. The 4 pieces from each testis were placed in one hexahedron of agarose gel 
and soaked in the organ culture medium containing 2x alpha-MEM (Sigma), 10% knockout serum replacement 
KSR (Sigma), 100 U/ml penicillin, 100 µg/ml streptomycin and 7% w/v sodium bicarbonate. Testis pieces were 
maintained in culture for 4 days and 10 µM BrdU (Sigma) was added to the medium 6 hours before harvesting. 
In vitro deletion of the floxed Ppp1r8 allele was obtained by addition of 2 µM (Z)-4-Hydroxytamoxifen (OHT) 
(Sigma-Aldrich) to the medium for 96 h. Finally, the 4 pieces of one agarose hexahedron were collectively embed-
ded in paraffin and all 4 pieces were included for the quantification of this experimental condition.
GFRA1-enriched cells (undifferentiated spermatogonia) were isolated from 12 days-old CTR and iKO mice, 
as described by Guan et al. (2009)41. Briefly, testicular cells were isolated by an enzymatic procedure using colla-
genase IV (Worthinghton biochem corp.) and dispase (Invitrogen), followed by enrichment of GFRA1-enriched 
spermatogonia through laminin (Sigma) selection. This laminin selection method is based on the expression of 
specific surface markers on SSCs, such as α6 integrin (Itga6) and β1-integrins (Itgb1). Since some of these recep-
tors bind the extracellular matrix molecule laminin, laminin can be used to enrich testicular cells for SSCs, as 
reported41–43. After enrichment, cells were co-cultured with freshly prepared MEF (mouse embryonic fibroblasts) 
as feeding cells. The MEFs had been pre-incubated with Mitomycin C (Sigma) and maintained in spermatogonia 
stem cells (SSCs) growth medium, containing MEM alfa medium (Thermo fisher scientific) and supplemented 
with 10% FBS, 100 U/ml penicillin, non-essential amino acids (Thermo fisher scientific), β-Mercaptoethanol 
(Sigma), N2-1 supplement (Thermo fisher scientific), recombinant GDNF (R&D systems; 4 ng/ml) and recom-
binant LIF (Sigma; 103 U/ml). NIPP1 deletion was induced by addition of 1 µM 4-OHT to the medium for 72 h. 
For the proliferation assay, 15 µM BrdU was added to the medium 5 hours before harvesting cells. The purity of 
the cells after laminin enrichment was assessed by quantifying the relative number of GFRA1+ cells in images 
from GFRA1 and DAPI stained cells. Two independent isolations after laminin selection were scored by selecting 
8 images randomly and scoring >180 cells for each isolation.
Immunohistochemistry. Testes fixed in Bouin’s (6 h) or 4% PFA (24 h) were embedded in paraffin and 
sectioned at a thickness of 6 µm. Testis sections were stained with Hematoxylin and Eosine (H&E) or the fibro-
sis marker Sirius red according to standard protocols. DNA was visualized by DAPI or Propidium Iodide (PI), 
as indicated. For the clarity of the pictures, the blue color of DAPI was often converted to red by image pro-
cessing. TUNEL assays were performed using the In-Situ-Cell-Death-Detection-Kit and Fluorescein (Roche) 
on paraffin-embedded testis tissue following the instructions of the manufacturer. Testis sections were immu-
nostained using the antibodies listed in Supplementary Table 3 and using the TSATM Fluorescein, TSATM Biotin 
system (PerkinElmer) or chromogenic detection using DAB (3,3′-diaminobenzidine). Detailed immunostaining 
protocols are available on request. The immunofluorescence images were acquired with a Leica TCS SPE laser 
(f). Representative images are shown. Arrows indicate GFRA1+ colonies. *Mouse embryonic fibroblast (MEF) 
nucleus. Scale bar, 10 μm. Quantification (n = 3) of stainings for incorporated BrdU (g) and apoptotic cells (h), 
as shown in panels (e) and (f), respectively. *Mouse embryonic fibroblast (MEF) nucleus. Scale bar, 10 μm. (i) 
Testis sections of tamoxifen-treated CTR and iKO mice at the indicated ages were stained for DNA (DAPI) and 
the undifferentiated spermatogonia marker GFRA1. Scale bar, 50 μm. (j) Quantification (n = 4) of the relative 
number of GFRA1+ cells per seminiferous tubule. (l) qRT-PCR analysis (n = 4) of the Gfra1 transcript at the 
indicated ages using Hprt as housekeeping gene for normalization. All data in this figure are represented as 
means ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001.
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scanning confocal system mounted on a Leica DMI 4000B microscope and equipped with a Leica ACS APO 20X 
objective. Quantifications shown in, Fig. 3b,g and h, Supplementary Fig. 3d and Supplementary Fig. 4b,c were 
performed by counting the number of cells stained with the indicated cell markers per seminiferous tubule (30 
randomly selected tubules per mouse, n = 4). Leica MM AF 2.1 software was used for quantification (10 pictures 
of 10x objective magnification were randomly selected per mouse testis) of the relative expression of PCNA 
(Figs 3c and 4f), NIPP1 (Fig. 4b and e, and Supplementary Fig. 1f), SOX9 (Supplementary Fig. 6b), and p16 
(Supplementary Fig. 4d) over DAPI (nucleus) signal. Quantification for incorporated BrdU and apoptopic cells 
in the GFRA1-enriched cell populations (Fig. 6g and h) were performed by counting the number of positive cells 
relative to the total number of cells in the colony (n = 3; eight colonies for each condition were analysed).
Biochemical procedures. Testes were homogenized using a dounce homogenizer (Sigma) and incubated 
in lysis buffer for 20 min at 4 °C. The lysis buffer comprised modified RIPA buffer (50 mM Tris-HCl at pH 7.4, 
1% Triton-X 100, 0.2% sodium deoxycholate, 0.2% sodium dodecyl sulfate (SDS), 1 mM EDTA, 0.3 M NaCl) or 
SDS-lysis buffer (50 mM Tris-HCl at pH 7.4, 2% SDS, 12% glycerol, 100 mM β-mercaptoethanol). Lysis buffers 
were supplemented with 20 mM NaF, 5 µM leupeptin, 0.5 mM phenylmethanesulfonyl fluoride, 0.5 mM benz-
amidine and 1 mM orthovanadate. The lysates were centrifuged for 5 min at 1800 × g and the supernatant was 
used for immunoblotting. The testis extracts for immunoblotting in Figs 1e, 2c, 3d and Supplementary Fig. 5 were 
prepared with modified RIPA, while SDS-lysis buffer was used in Supplementary Fig. 7c. Immunoblotting was 
performed following 10% SDS- PAGE with the indicated antibodies (Supplementary Table 3). Immunoblots were 
visualized using ECL reagent (Perkin Elmer) in an ImageQuant LAS4000 imaging system (GE Healthcare) (see 
Supplementary Fig. 8 for uncropped blots) and were quantified using ImageQuant TL software (GE Healthcare).
RNA sequencing and Quantitative Reverse Transcriptase PCR (qRT-PCR). Total RNA was 
isolated from 40 mg of snap-frozen mouse testis using the GenEluteTM. Mammalian Total RNA Miniprep kit 
(Sigma-aldrich). RNA integrity of the samples used for RNA sequencing was assessed using a Bioanalyser 2100 
(Agilent). Library preparation, sequencing and statistical analysis of the RNA sequencing data were performed by 
VIB Nucleomics Core, as detailed in the Supplementary information.
Complementary DNA (cDNA) was synthetized from 2 µg of total RNA using oligo dT primers (Sigma-aldrich) 
RevertAid Premium Reverse Transcriptase and RiboLock RNase inhibitor enzymes (Fermentas). About 1.2% of 
the cDNA was amplified by PCR in duplicate using SYBR Green qPCR Mix (Invitrogen) and a Rotorgene detec-
tion system (Corbett Research). To compare the relative amount of target genes in different samples, values were 
normalized to the housekeeping gene Hprt (Hypoxanthine-guanine phosphoribosyltransferase) or a cell-type 
specific gene as indicated in the Figures. qRT-PCR primers are listed in Supplementary Table 4.
Statistical analysis. All statistical analysis was performed using GraphPad Prism software. Two-way 
unpaired (Figs 1–5 and 6i–l, Supplementary Figs 1–3 and 4–6) or paired (Fig. 6e–h) student’s t-test, and Pearson’s 
correlation test (Supplementary Fig. 6f) were used.
Data availability. All gene expression data are available at GEO under the accession number GSE83145.
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